{
    "doi": "https://doi.org/10.1182/blood.V122.21.370.370",
    "article_title": "The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial \u201cLymphome Du Manteau 2010 SA\u201d ",
    "article_date": "November 15, 2013",
    "session_type": "623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models",
    "abstract_text": "This prospective phase II trial (Nov 2011- Dec 2012), supported by the LYSA group, aimed to evaluate the impact on PFS of the RiBVD regimen in newly diagnosed, previously untreated, elderly MCL patients (>65 years or not eligible for ASCT) (NCT01457144). Inclusion criteria were: WHO 2008 MCL not previously treated, CD20 positive, ECOG 0-2, AA stage II-IV, no CNS involvement or active HBV/HCV/HIV infection. Patients were scheduled to receive a total of 6 cycles of the RiBVD regimen, if they responded (IWG criteria) after 4 cycles. The regimen was administered every 4 weeks with Rituximab 375 mg/m\u00b2 IV on day(D)1, Bendamustine 90 mg/m\u00b2 IV on D1 and 2, Dexamethasone 40 mg/m\u00b2 IV on D2 and bortezomib (Velcade\u00ae) 1.3 mg/m\u00b2 subcutaneously on D1, 4, 8 and 11. Primary prophylaxis with acyclovir was mandatory for Herpes virus reactivation, but there was no recommendation for bacterial prevention. Herein we present preliminary analysis of the trial after 4 RiBVD cycles. Results : A total of 76 patients were included, one was excluded because of HBV active disease and 5 had insufficient data reported in the database . To date we analyzed 70 patients . Patients characteristics: sex ratio M/F 49/21, median age 72 years (y) [64-83] (2 patients were 64 y old), AAstage II/III-IV 5/65, ECOG 0-1/2 59/11, MIPI score low/intermediate/high 3/19/48. Response: 61 responded (ORR=87%), with 19 in PR (26%) and 42 in CR/CRu (60%). Four patients died from pneumonia (n=1), cardiac arrest (n=2) and one following Progressive Multifocal Leukoencephalopathy. Three patients have progressed after 3 cycles. Sixty one patients were analysed by PETscan after 4 cycles, 39 (64%) reached a CR (30 were in CR/CRu and 9 in PR) and 22 remained PET positive (11 patients were in CR/CRu, 10 in PR and 1 stable). RiBVD cycles : 271 cycles were administered out of 280 planned (97%). Twenty four (9%) were delayed, 10 for toxicity. All but one planned Bendamustine doses (n=542) were administered with dosing modified 17 times (3%), mostly for hematological toxicity (n=14). Regarding Bortezomib, 79% (1028/1084) of planned doses were administered, it was prematurely stopped (56, 4%) for neurotoxicity (10 instances) or hematological side effects (46). Rituximab was not administered in 4 instances. Hematologic toxicities : Over the 271 cycles administered, neutropenia was reported in 104 cycles [56 grade 3/4 (g3/4) (21%)], 2.5% with fever; thrombopenia in 181 cycles [41 g3/4 (15%)]; anemia in 210 cycles, [6 g3/4 (2%)]. Non-hematologic toxicities : Reported in >10% of the cycles were : allergic reactions (10.3%, g3/4 <1%), fatigue (40%, g3/4 5%), fever without neutropenia (12%, g3/4 none), weight loss (12%, g3/4 0%), cutaneous rash (12%, g3/4 1.5%), gastrointestinal (40%, g3/4 1.5% ; diarrhea 8%, constipation 17% or emesis 15%), elevated transaminases (14%, g3/4 1%), creatinin (13%, g3/4 none), or glucose (18%, g3/4 1%) ; neuropathy (sensitive or pain) (25%, g3/4 4%). Serious adverse events (SAE) additional to the 4 deaths, were 12 infections including 3 pneumonias (no pneumocystosis), one listeriosis and 2 herpes zoster. Four febrile neutropenia and 3 cutaneous hypersensitivity episodes were also reported. Conclusion Despite 4 toxic deaths (6%), toxicity appears acceptable and manageable. In particular, subcutaneous bortezomib shows markedly decreased neurotoxicity compared to the IV form. This interim analysis shows that four cycles of RiBVD are very effective for untreated elderly MCL patients (ORR 87%) with a high response rate (CR/CRu 60%) which has been shown to be predictive of a long duration of response. An update of these results will be presented at the ASH meeting together with the molecular response rates after 4 cycles. Disclosures: Gressin: Pfizer: Consultancy; Mundipharma: Consultancy. Cartron: Roche: Membership on an entity\u2019s Board of Directors or advisory committees.",
    "topics": [
        "bendamustine",
        "bortezomib",
        "complete remission",
        "dexamethasone",
        "mantle-cell lymphoma",
        "older adult",
        "rituximab",
        "weight reduction",
        "toxic effect",
        "electrocorticogram"
    ],
    "author_names": [
        "Remy Gressin, MD",
        "Mary Callanan, MD, PhD",
        "Nicolas Daguindau, MD",
        "Adrian Tempescul, MD",
        "Sylvain Carras",
        "Guillaume Cartron, MD, PhD",
        "Anne Schmitt, MD",
        "Roch Houot, MD, PhD",
        "Caroline Dartigeas, MD",
        "Jean Michel Pignon, MD",
        "Selim Corm, MD, PhD",
        "Anne Banos, MD",
        "Jehan Dupuis, MD",
        "Christiane Mounier, MD",
        "Margareth Macro, MD",
        "Joel Fleury, MD",
        "Fabrice Jardin, MD, PhD",
        "Lionel Kardin, MD",
        "Gandhi Damaj, MD",
        "Pierre Feugier, MD, PhD",
        "luc Matthieu Fornacker, MD",
        "Cecile molucon Chabrot, MD",
        "Veronique Dorvaux, MD",
        "Krimo Bouabdallah, MD",
        "Sandy Amorin, MD",
        "Reda Garidi, MD",
        "Laurent Voillat, MD",
        "Bertrand Joly, MD",
        "Philippe Solal-C\u00e9ligny, MD",
        "Nadine Morineau, MD",
        "Marie Pierre Moles, MD",
        "Hacene Zerazhi, MD",
        "Jean Fontan, MD",
        "Yazid Arkam, MD",
        "Magda Alexis, MD",
        "Vincent Delwail, MD",
        "Jean Pierre Vilque, MD",
        "Loic Ysebaert, MD PhD",
        "Steven Le Gouill, MD, PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Remy Gressin, MD",
            "author_affiliations": [
                "Haematology and INSERM, U 823, Institut Albert Bonniot, University Hospital Grenoble, Grenoble, France, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Mary Callanan, MD, PhD",
            "author_affiliations": [
                "Oncogenic Pathways in the Haematological Malignancies, INSERM, U823,, Grenoble, France, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicolas Daguindau, MD",
            "author_affiliations": [
                "hematology, Hospital Annecy, Annecy, France, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Adrian Tempescul, MD",
            "author_affiliations": [
                "Hematology, Brest University Hospital, Brest, France, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sylvain Carras",
            "author_affiliations": [
                "Hematology, University Hospital Grenoble, Grenoble, France, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guillaume Cartron, MD, PhD",
            "author_affiliations": [
                "D\u00e9partement d\u2019H\u00e9matologie Clinique, Centre Hospitalier Universitaire Montpellier, Montpellier, France, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anne Schmitt, MD",
            "author_affiliations": [
                "hematology and oncology, institut Bergonie, Bordeaux, France, "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roch Houot, MD, PhD",
            "author_affiliations": [
                "haematology, University hospital Rennes, Rennes, France, "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caroline Dartigeas, MD",
            "author_affiliations": [
                "Oncology and Haematology, university hospital Tours, Tours, France, "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jean Michel Pignon, MD",
            "author_affiliations": [
                "haematology, hospital, dunkerque, France, "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Selim Corm, MD, PhD",
            "author_affiliations": [
                "Hematology and Oncology, Hospital, Chamb\u00e9ry, France, "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anne Banos, MD",
            "author_affiliations": [
                "Hematology, Centre Hospitalier de la C\u00f4te Basque, Bayonne, France, "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jehan Dupuis, MD",
            "author_affiliations": [
                "Hematology, Henri Mondor Hospital, Creteil, France, "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christiane Mounier, MD",
            "author_affiliations": [
                "Haematology, Institut de cancerologie de la loire, Saint Priest, France, "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Margareth Macro, MD",
            "author_affiliations": [
                "hematology, university hospital Caen, caen, France, "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Joel Fleury, MD",
            "author_affiliations": [
                "hematology, Institut, clermont ferrand, France, "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabrice Jardin, MD, PhD",
            "author_affiliations": [
                "Inserm U918, Rouen, France, "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lionel Kardin, MD",
            "author_affiliations": [
                "hematology, University Hospital Lyon, Lyon, France, "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gandhi Damaj, MD",
            "author_affiliations": [
                "D\u00e9partement d'h\u00e9matologie clinique, Centre hospitalier universitaire, Amiens, France, "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pierre Feugier, MD, PhD",
            "author_affiliations": [
                "Hematology, University Hospital, Vandoeuvre Les Nancy, France, "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "luc Matthieu Fornacker, MD",
            "author_affiliations": [
                "hematology, University Hospital, Strasbourg, France, "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cecile molucon Chabrot, MD",
            "author_affiliations": [
                "hematology, University Hospital, clermont ferrand, France, "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Veronique Dorvaux, MD",
            "author_affiliations": [
                "hematology, hospital, METZ, France, "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Krimo Bouabdallah, MD",
            "author_affiliations": [
                "Service d'H\u00e9matologie et de Th\u00e9rapie Cellulaire, University Hospital of Bordeaux, Pessac, France, "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sandy Amorin, MD",
            "author_affiliations": [
                "hematology, University Hospital PARIS HOPITAL SAINT LOUIS, PARIS, France, "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Reda Garidi, MD",
            "author_affiliations": [
                "HEMATOLOGY, HOSPITAL, SAINT QUENTIN, France, "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Laurent Voillat, MD",
            "author_affiliations": [
                "Hematology, HOSPITAL Chalons, Chalons sur Soane, France, "
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bertrand Joly, MD",
            "author_affiliations": [
                "hematology, HOSIPTAL, Corbeil-Essonnes, France, "
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Philippe Solal-C\u00e9ligny, MD",
            "author_affiliations": [
                "Centre Jean Bernard, Le Mans, France, "
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nadine Morineau, MD",
            "author_affiliations": [
                "Hematology, Centre Catherine de Sienne, Nantes, France, "
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marie Pierre Moles, MD",
            "author_affiliations": [
                "hematology, university hopsital, Angers, France, "
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Hacene Zerazhi, MD",
            "author_affiliations": [
                "hematology, hospital, Avignon, France, "
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jean Fontan, MD",
            "author_affiliations": [
                "hematology, university hospital, Besan\u00e7on, France, "
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Yazid Arkam, MD",
            "author_affiliations": [
                "hematology, hospital, mulhouse, France, "
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Magda Alexis, MD",
            "author_affiliations": [
                "Hematology, hospital, Orleans, France, "
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vincent Delwail, MD",
            "author_affiliations": [
                "cic802 Inserm, university hospital, Poitiers, France, "
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jean Pierre Vilque, MD",
            "author_affiliations": [
                "hematology, CENTRE FRANCOIS BACLESSE, Caen, France, "
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Loic Ysebaert, MD PhD",
            "author_affiliations": [
                "Hematology, University Hospital of Toulouse, Toulouse, France, "
            ],
            "author_rank": 38,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Steven Le Gouill, MD, PhD",
            "author_affiliations": [
                "Hematology, CHU Nantes, Nantes, France"
            ],
            "author_rank": 39,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-25T21:38:13",
    "is_scraped": "1"
}